BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,219,248 | +160.0% | 2,573,340 | +158.5% | 0.01% | +200.0% |
Q2 2023 | $7,008,201 | +105429.3% | 995,483 | +25.0% | 0.00% | 0.0% |
Q1 2023 | $6,641 | -64.0% | 796,299 | -50.4% | 0.00% | -71.4% |
Q4 2022 | $18,433 | -99.9% | 1,605,694 | -15.6% | 0.01% | -30.0% |
Q3 2022 | $23,975,000 | +17.7% | 1,902,821 | -1.2% | 0.01% | +25.0% |
Q2 2022 | $20,375,000 | -47.5% | 1,925,834 | -21.6% | 0.01% | -38.5% |
Q1 2022 | $38,775,000 | +18.6% | 2,457,215 | +4.1% | 0.01% | +30.0% |
Q4 2021 | $32,698,000 | -6.3% | 2,360,925 | -2.8% | 0.01% | -9.1% |
Q3 2021 | $34,914,000 | -13.9% | 2,429,686 | -5.3% | 0.01% | -8.3% |
Q2 2021 | $40,559,000 | +59.2% | 2,565,420 | +2.4% | 0.01% | +50.0% |
Q1 2021 | $25,469,000 | +117.4% | 2,504,355 | +59.3% | 0.01% | +100.0% |
Q4 2020 | $11,715,000 | +109.7% | 1,572,514 | -3.3% | 0.00% | +100.0% |
Q3 2020 | $5,587,000 | -30.5% | 1,626,607 | -3.6% | 0.00% | -33.3% |
Q2 2020 | $8,037,000 | +125.6% | 1,686,808 | -5.3% | 0.00% | +50.0% |
Q1 2020 | $3,562,000 | -3.4% | 1,781,249 | +66.7% | 0.00% | +100.0% |
Q4 2019 | $3,687,000 | +56.4% | 1,068,498 | +29.8% | 0.00% | 0.0% |
Q3 2019 | $2,357,000 | -24.0% | 822,882 | +0.6% | 0.00% | 0.0% |
Q2 2019 | $3,101,000 | – | 818,233 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |